Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
VRTX | VERTEX PHARMACEUTICALS INC / MA | EVP, Cell & Genetic Therapies | $13.4 M | May 5, 2023 | ||
ACET | Adicet Bio, Inc. | Director | Aug 14, 2023 |
Sym | Company | Class | Transaction | % | Value $ | Price $ | Shares | Shares After | Date | Ownership |
---|